Habibe Kafes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Habibe Kafes has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Bahar Tekin Tak
Department of Cardiology, Health Sciences University, Ankara City Hospital, Ankara, Turkey
5 shared publications - Firdevs Aysenur Ekizler
Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
5 shared publications - Dursun Aras
Department of Cardiology, Istanbul Medipol University, Istanbul 34815, Türkiye
4 shared publications - Ozcan Ozeke
Department of Cardiology University of Health Sciences, Ankara Bilkent City Hospital Ankara Turkiye
4 shared publications - Serkan Cay
Division of Arrhythmia and Electrophysiology, Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
4 shared publications - Serkan Topaloglu
Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
4 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3063
Fibrosis-4 Index as a Marker of Systemic Fibrotic Burden and Its Association with Left Atrial Thrombus in Nonvalvular Paroxysmal Atrial Fibrillation
Background/Objectives: Left atrial thrombus (LAT) is a clinically important finding in nonvalvular atrial fibrillation (AF). The Fibrosis-4 (FIB-4) index reflects systemic fibrotic burden. We investigated the association between FIB-4 and LAT. Methods: This retrospective study included 859 patients with nonvalvular paroxysmal AF undergoing transesophageal echocardiography (TEE). ROC analysis and multivariable logistic regression were performed. Results: Left atrial thrombus (LAT) was detected in 10.2% of patients. Patients with thrombus exhibited significantly higher admission FIB-4 scores compared to those without (1.5 vs. 1.1, p < 0.001). ROC analysis yielded an optimal FIB-4 cut-off of 1.47 (AUC: 0.65, 95% CI: 0.57–0.70, p < 0.001), providing 71.6% sensitivity and 72.0% specificity. After adjusting for CHA2DS2-VASc score, renal function, and left atrial diameter, a FIB-4 > 1.47 remained a strong independent predictor of LAT (OR: 5.200; 95% CI: 3.105–8.708, p < 0.001). However, the addition of FIB-4 to the CHA2DS2-VASc score did not significantly improve discriminatory performance (p = 0.314, DeLong’s test). Spearman’s correlation showed a modest relationship between FIB-4 and CHA2DS2-VASc (r = 0.321). Conclusions: Elevated FIB-4 index values are independently associated with LAT in patients with paroxysmal AF. This simple, noninvasive marker may reflect a systemic fibro-inflammatory milieu that promotes an atrial thrombogenic substrate beyond traditional clinical risk scores.
- 17 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3063
Open AccessFibrosis-4 Index as a Marker of Systemic Fibrotic Burden and Its Association with Left Atrial Thrombus in Nonvalvular Paroxysmal Atrial Fibrillation
Background/Objectives: Left atrial thrombus (LAT) is a clinically important finding in nonvalvular atrial fibrillation (AF). The Fibrosis-4 (FIB-4) index reflects systemic fibrotic burden. We investigated the association between FIB-4 and LAT. Methods: This retrospective study included 859 patients with nonvalvular paroxysmal AF undergoing transesophageal echocardiography (TEE). ROC analysis and multivariable logistic regression were performed. Results: Left atrial thrombus (LAT) was detected in 10.2% of patients. Patients with thrombus exhibited significantly higher admission FIB-4 scores compared to those without (1.5 vs. 1.1, p < 0.001). ROC analysis yielded an optimal FIB-4 cut-off of 1.47 (AUC: 0.65, 95% CI: 0.57–0.70, p < 0.001), providing 71.6% sensitivity and 72.0% specificity. After adjusting for CHA2DS2-VASc score, renal function, and left atrial diameter, a FIB-4 > 1.47 remained a strong independent predictor of LAT (OR: 5.200; 95% CI: 3.105–8.708, p < 0.001). However, the addition of FIB-4 to the CHA2DS2-VASc score did not significantly improve discriminatory performance (p = 0.314, DeLong’s test). Spearman’s correlation showed a modest relationship between FIB-4 and CHA2DS2-VASc (r = 0.321). Conclusions: Elevated FIB-4 index values are independently associated with LAT in patients with paroxysmal AF. This simple, noninvasive marker may reflect a systemic fibro-inflammatory milieu that promotes an atrial thrombogenic substrate beyond traditional clinical risk scores.
- Open Access
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (3)
INFLAMMATION INDICES PREDICT STENT THROMBOSIS IN GERIATRIC PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
Introduction: The objective of this investigation was to determine whether the systemic immune-inflammation index (SII) and pan-immune-inflammation value (PIV), which serve as comprehensive indicators of systemic inflammatory pathways, possess the prognostic capacity to identify future stent thrombosis (ST) in geriatric STEMI patients. Materials and Method: We comprehensively screened a consecutive cohort of 1,683 elderly individuals (aged 75.3 ± 6.8 years; 64.6% male) who had been treated with primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Stratification was performed based on the clinical manifestation of angiographically confirmed ST during follow-up. Both SII and PIV scores were computed from standard complete blood counts obtained at the time of initial clinical presentation. Results: Over an average follow-up duration of 30 ± 10 months, definite ST was documented in 104 individuals (6.2%). Patients experiencing ST exhibited distinct baseline profiles, characterized by a higher prevalence of tobacco use and hypertension, a greater frequency of early dual antiplatelet therapy (DAPT) cessation (<30 days), prolonged total stent lengths, and markedly elevated baseline high-sensitivity C-reactive protein (hs-CRP), SII, and PIV levels. In multivariable Cox proportional hazards modeling, both admission PIV and SII emerged as robust, standalone indicators of subsequent ST. Furthermore, correlation analyses demonstrated that hs-CRP levels fluctuated in tandem with both SII (r=0.342, p<0.001) and PIV (r=0.268, p<0.001) values. Conclusion: In summary, these data demonstrate that baseline immunoinflammatory indices serve as independent and highly reliable indicators of subsequent ST development within the high-risk geriatric cohort treated with primary PCI for STEMI. Keywords: Aged; Biomarkers; Inflammation; Stent; Thrombosis; ST Elevation Myocardial Infarction.
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (3)
Open AccessINFLAMMATION INDICES PREDICT STENT THROMBOSIS IN GERIATRIC PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
Introduction: The objective of this investigation was to determine whether the systemic immune-inflammation index (SII) and pan-immune-inflammation value (PIV), which serve as comprehensive indicators of systemic inflammatory pathways, possess the prognostic capacity to identify future stent thrombosis (ST) in geriatric STEMI patients. Materials and Method: We comprehensively screened a consecutive cohort of 1,683 elderly individuals (aged 75.3 ± 6.8 years; 64.6% male) who had been treated with primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Stratification was performed based on the clinical manifestation of angiographically confirmed ST during follow-up. Both SII and PIV scores were computed from standard complete blood counts obtained at the time of initial clinical presentation. Results: Over an average follow-up duration of 30 ± 10 months, definite ST was documented in 104 individuals (6.2%). Patients experiencing ST exhibited distinct baseline profiles, characterized by a higher prevalence of tobacco use and hypertension, a greater frequency of early dual antiplatelet therapy (DAPT) cessation (<30 days), prolonged total stent lengths, and markedly elevated baseline high-sensitivity C-reactive protein (hs-CRP), SII, and PIV levels. In multivariable Cox proportional hazards modeling, both admission PIV and SII emerged as robust, standalone indicators of subsequent ST. Furthermore, correlation analyses demonstrated that hs-CRP levels fluctuated in tandem with both SII (r=0.342, p<0.001) and PIV (r=0.268, p<0.001) values. Conclusion: In summary, these data demonstrate that baseline immunoinflammatory indices serve as independent and highly reliable indicators of subsequent ST development within the high-risk geriatric cohort treated with primary PCI for STEMI. Keywords: Aged; Biomarkers; Inflammation; Stent; Thrombosis; ST Elevation Myocardial Infarction.
- Open Access
- 1 January 2022
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 9 (2) , 93-101
Which is the best for the warfarin monitoring: Following up by fixed or variable physician?
OBJECTIVE: Warfarin therapy has some difficulties in terms of close monitoring and dosage. This study aims to evaluate the effect of same-fixed versus different-variable physician-based monitoring of warfarin therapy on treatment quality and clinical end-points. METHODS: A total of 625 consecutive patients requiring warfarin treatment were enrolled at seven centers. INR values of the patients measured at each visit and registered to hospital database were recorded. Time in therapeutic range (TTR) was calculated using linear interpolation method (Rosendaal's method). A TTR value of >= 65% was considered as effective warfarin treatment. If a patient was evaluated by the same-fixed physician at each INR visit, was categorized into the same-physician (SP) group. In contrast, if a patient was evaluated by different-variable physicians at each INR visit, was categorized into variable physician (VP) group. Enrolled patients were followed up for bleeding and embolic events. RESULTS: One hundred and fifty-six patients (24.9%) were followed by SP group, 469 (75.1%) patients were followed by VP group. Median TTR value of the VP group was lower than that of SP group (56.2% vs. 65.1%, respectively, p=0.009). During median 25.5 months (9-36) of follow-up, minor bleeding, major bleeding and cerebral embolic event rates were higher in VP group compared to SP group (p<0.001, p=0.023, p<0.001, respectively). In multivariate analysis, INR monitoring by VP group was found to be an independent predictor of increased risk of bleeding events (OR 2.55, 95% CI 1.64-3.96, p<0.001) and embolism (OR 3.42, 95% CI 1.66-7.04, p=0.001). CONCLUSION: INR monitoring by same physician was associated with better TTR and lower rates of adverse events during followup. Hence, it is worth encouraging an SP-based outpatient follow-up system at least for where warfarin therapy is the only choice.
- 1 January 2022
- Published by Kare Publishing in Northern Clinics of Istanbul
- Vol. 9 (2) , 93-101
Open AccessWhich is the best for the warfarin monitoring: Following up by fixed or variable physician?
OBJECTIVE: Warfarin therapy has some difficulties in terms of close monitoring and dosage. This study aims to evaluate the effect of same-fixed versus different-variable physician-based monitoring of warfarin therapy on treatment quality and clinical end-points. METHODS: A total of 625 consecutive patients requiring warfarin treatment were enrolled at seven centers. INR values of the patients measured at each visit and registered to hospital database were recorded. Time in therapeutic range (TTR) was calculated using linear interpolation method (Rosendaal's method). A TTR value of >= 65% was considered as effective warfarin treatment. If a patient was evaluated by the same-fixed physician at each INR visit, was categorized into the same-physician (SP) group. In contrast, if a patient was evaluated by different-variable physicians at each INR visit, was categorized into variable physician (VP) group. Enrolled patients were followed up for bleeding and embolic events. RESULTS: One hundred and fifty-six patients (24.9%) were followed by SP group, 469 (75.1%) patients were followed by VP group. Median TTR value of the VP group was lower than that of SP group (56.2% vs. 65.1%, respectively, p=0.009). During median 25.5 months (9-36) of follow-up, minor bleeding, major bleeding and cerebral embolic event rates were higher in VP group compared to SP group (p<0.001, p=0.023, p<0.001, respectively). In multivariate analysis, INR monitoring by VP group was found to be an independent predictor of increased risk of bleeding events (OR 2.55, 95% CI 1.64-3.96, p<0.001) and embolism (OR 3.42, 95% CI 1.66-7.04, p=0.001). CONCLUSION: INR monitoring by same physician was associated with better TTR and lower rates of adverse events during followup. Hence, it is worth encouraging an SP-based outpatient follow-up system at least for where warfarin therapy is the only choice.
- 23 January 2020
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (3) , 307-313
The Association Between Whole Blood Viscosity and Obstructive Coronary Artery Disease in Patients with Premature Acute Coronary Syndrome
- 23 January 2020
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (3) , 307-313
The Association Between Whole Blood Viscosity and Obstructive Coronary Artery Disease in Patients with Premature Acute Coronary Syndrome
- 8 January 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (3) , 201-210
Relationship Between Apical Thrombus Formation and Blood Viscosity in Acute Anterior Myocardial Infarction Patients
Aim: This study sought to investigate the predictive value of whole blood viscosity (WBV) to identify high-risk patients who will develop an apical thrombus during the acute phase of anterior trans...
- 8 January 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (3) , 201-210
Relationship Between Apical Thrombus Formation and Blood Viscosity in Acute Anterior Myocardial Infarction Patients
Aim: This study sought to investigate the predictive value of whole blood viscosity (WBV) to identify high-risk patients who will develop an apical thrombus during the acute phase of anterior trans...
- Open Access
- 6 October 2019
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 25 (3) , 149-156
Fragmented QRS as a candidate marker for left ventricular nonrecovery in patients with peripartum cardiomyopathy
Background: Fragmented QRS (fQRS) complex, with various morphology, has been recently described as a diagnostic criterion of several cardiac diseases. However, there are little data regarding the prognostic role of fQRS in peripartum cardiomyopathy (PPCM) patients. We aimed to investigate the effect of fQRS on predicting left ventricular (LV) nonrecovery in patients with peripartum cardiomyopathy (PPCM).Methods: Ninety patients (mean age: 34.7 ± 6.5 years) with the diagnosis of PPCM were analyzed retrospectively. The median follow‐up period of was 67.0 (12.0–192.0) months. Fragmented QRS was defined as the presence of various RSR’ patterns (QRS duration < 120 ms) with or without Q wave, which include an additional R wave (R’ prime) or notching of the R wave or S wave, or the presence of more than one R' (fragmentation) without typical bundle branch block. Recovery of LV function was defined as the presence of LV ejection fraction (EF) >45%.Results: Of the patients, 54 (60%) did not recover LV function at the last follow‐up visit (nonrecovery group), while 36 of the patients (40%) exhibited LV recovery (recovery group). LV ejection fraction (EF) and fQRS were identified as independent predictors of LV nonrecovery in patients with PPCM (odds ratio OR: 5.546, 95% confidence interval CI: 0.792–0.979, p = .019 and OR: 5.986, 95% CI: 1.313–11.787, p = .014, respectively).Conclusion: Our data firstly indicated that presence of fQRS was a significant predictor of LV nonrecovery in patients with PPCM. The fQRS might assist in identifying high‐risk patients.
- 6 October 2019
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 25 (3) , 149-156
Open AccessFragmented QRS as a candidate marker for left ventricular nonrecovery in patients with peripartum cardiomyopathy
Background: Fragmented QRS (fQRS) complex, with various morphology, has been recently described as a diagnostic criterion of several cardiac diseases. However, there are little data regarding the prognostic role of fQRS in peripartum cardiomyopathy (PPCM) patients. We aimed to investigate the effect of fQRS on predicting left ventricular (LV) nonrecovery in patients with peripartum cardiomyopathy (PPCM).Methods: Ninety patients (mean age: 34.7 ± 6.5 years) with the diagnosis of PPCM were analyzed retrospectively. The median follow‐up period of was 67.0 (12.0–192.0) months. Fragmented QRS was defined as the presence of various RSR’ patterns (QRS duration < 120 ms) with or without Q wave, which include an additional R wave (R’ prime) or notching of the R wave or S wave, or the presence of more than one R' (fragmentation) without typical bundle branch block. Recovery of LV function was defined as the presence of LV ejection fraction (EF) >45%.Results: Of the patients, 54 (60%) did not recover LV function at the last follow‐up visit (nonrecovery group), while 36 of the patients (40%) exhibited LV recovery (recovery group). LV ejection fraction (EF) and fQRS were identified as independent predictors of LV nonrecovery in patients with PPCM (odds ratio OR: 5.546, 95% confidence interval CI: 0.792–0.979, p = .019 and OR: 5.986, 95% CI: 1.313–11.787, p = .014, respectively).Conclusion: Our data firstly indicated that presence of fQRS was a significant predictor of LV nonrecovery in patients with PPCM. The fQRS might assist in identifying high‐risk patients.
- 1 April 2019
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (1) , 54-60
Repolarization Parameters in Patients with Premature Coronary Artery Disease
- 1 April 2019
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (1) , 54-60
Repolarization Parameters in Patients with Premature Coronary Artery Disease